A

Alder Biopharmaceuticals Inc. (Nasdaq: ALDR)

47 employees

Alder Biopharmaceuticals uses their proprietary technologies to accelerate antibody discovery and development.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2004

Funding rounds raised

Total raised

$250M

from 14 investors over 14 rounds

A

Alder Biopharmaceuticals Inc. (Nasdaq: ALDR) raised $250M on January 8, 2018

Investors: Redmile Group

A

Alder Biopharmaceuticals Inc. (Nasdaq: ALDR) raised $38M on April 19, 2012

Investors: H.I.G. Capital, Ventures West, Delphi Ventures, Sevin Rosen Funds and Washington Research Foundation

A

Alder Biopharmaceuticals Inc. (Nasdaq: ALDR) raised $40M on December 1, 2007

Investors: Delphi Ventures

A

Alder Biopharmaceuticals Inc. (Nasdaq: ALDR) raised $16M on July 1, 2006

Investors: Sevin Rosen Funds, Ventures West, H.I.G. Capital and Washington Research Foundation

A

Alder Biopharmaceuticals Inc. (Nasdaq: ALDR) raised $11M on July 1, 2005

Investors: Washington Research Foundation, Sevin Rosen Funds and Ventures West

FAQ